duvelisib,onureg
yakult honsha,secura bio,bms
['oral azacitidine', 'duvelisib']
tomorrow at #asco22, shares findings from a phase 1 trial in progress evaluating duvelisib combined with oral azacitidine for relapsed lymphoid malignancies. check out poster #238b. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.